These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2629459)

  • 21. Evidence that cell surface heparan sulfate is involved in the high affinity thrombin binding to cultured porcine aortic endothelial cells.
    Shimada K; Ozawa T
    J Clin Invest; 1985 Apr; 75(4):1308-16. PubMed ID: 3157703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neural cell adhesion molecule (NCAM) heparin binding domain binds to cell surface heparan sulfate proteoglycans.
    Kallapur SG; Akeson RA
    J Neurosci Res; 1992 Dec; 33(4):538-48. PubMed ID: 1484387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autoantibodies to heparin polysaccharides bind to vascular endothelial cells].
    Shibata S
    Rinsho Byori; 1998 Dec; 46(12):1205-9. PubMed ID: 9916505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.
    Booth BA; Boes M; Andress DL; Dake BL; Kiefer MC; Maack C; Linhardt RJ; Bar K; Caldwell EE; Weiler J
    Growth Regul; 1995 Mar; 5(1):1-17. PubMed ID: 7538367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of endothelial cell-derived growth factor (ECDGF) by heparin.
    Gajdusek CM
    J Cell Physiol; 1984 Oct; 121(1):13-21. PubMed ID: 6480707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histidine-rich glycoprotein does not interfere with interactions between antithrombin III and heparin-like compounds on vascular endothelial cells.
    Shimada K; Kawamoto A; Matsubayashi K; Ozawa T
    Blood; 1989 Jan; 73(1):191-3. PubMed ID: 2910359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of abnormal antithrombin-III Toyama with cultured porcine aortic endothelial cells.
    Saito S; Takahashi K; Sakuragawa N
    Thromb Res; 1988 Apr; 50(1):19-25. PubMed ID: 3400080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface.
    Adachi T; Fukushima T; Usami Y; Hirano K
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):523-7. PubMed ID: 8424793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium-dependent heparin-like ligands for L-selectin in nonlymphoid endothelial cells.
    Norgard-Sumnicht KE; Varki NM; Varki A
    Science; 1993 Jul; 261(5120):480-3. PubMed ID: 7687382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the control of the plasma contact activation system on human endothelium: comparisons with heparin surface.
    Sánchez J; Olsson P
    Thromb Res; 1999 Jan; 93(1):27-34. PubMed ID: 10065896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anticoagulant role of heparin-like molecules in the endothelial cell surface in hemostasis--endothelial heparin-like molecules.
    Shimada K; Ozawa T
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1604-9. PubMed ID: 3551438
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of a heparin-binding protein using monoclonal antibodies that block heparin binding to porcine aortic endothelial cells.
    Patton WA; Granzow CA; Getts LA; Thomas SC; Zotter LM; Gunzel KA; Lowe-Krentz LJ
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):461-9. PubMed ID: 7487882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycosaminoglycans bind human IL-27 and regulate its activity.
    Cavé MC; Maillard S; Hildenbrand K; Mamelonet C; Feige MJ; Devergne O
    Eur J Immunol; 2020 Oct; 50(10):1484-1499. PubMed ID: 32483835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin stimulates the release of glycosaminoglycans from cultured human endothelial cells.
    Kaji T; Sakuragawa N
    Thromb Res; 1990 Jan; 57(1):163-8. PubMed ID: 2300921
    [No Abstract]   [Full Text] [Related]  

  • 36. Internalization and metabolism of endogenous heparin by cultured endothelial cells.
    Vannucchi S; Pasquali F; Chiarugi V; Ruggiero M
    Biochem Biophys Res Commun; 1986 Oct; 140(1):294-301. PubMed ID: 3778451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface properties of cultured endothelial cells.
    Busch C; Ljungman C; Heldin CM; Waskson E; Obrink B
    Haemostasis; 1979; 8(3-5):142-8. PubMed ID: 389754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of the anticoagulant activity of glycosaminoglycans on the surface of the vascular endothelium by endotoxin and neutrophils: evaluation by an amidolytic assay.
    Heyderman RS; Klein NJ; Shennan GI; Levin M
    Thromb Res; 1992 Sep; 67(6):677-85. PubMed ID: 1440532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potency of heparin-like activity of glycosaminoglycans released by human endothelial cells in culture.
    Shimada K; Kusumoto I; Ozawa T
    Experientia; 1985 May; 41(5):671-3. PubMed ID: 3996545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin degradation in the endothelial cells.
    Barzu T; van Rijn JL; Petitou M; Tobelem G; Caen JP
    Thromb Res; 1987 Sep; 47(5):601-9. PubMed ID: 3672438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.